Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma

Cancer Biology and Therapy

Volumn 14, Issue 12, 2013, Pages 1133-1142

  Liu, Xiong ^a   Luo, Hua Nan ^a   Tian, Wen Dong ^a   Lu, Juan ^a   Li, Gang ^a   Wang, Lu ^a   Zhang, Bao ^a   Liang, Bi Jun ^a   Peng, Xiao Hong ^a   Lin, Shao Xiong ^a   Peng, Ying ^b   Li, Xiang Ping ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Biomarker; Diagnosis; MiRNA; Nasopharyngeal carcinoma; NPC; Plasma; Prognosis

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 16; MICRORNA 21; MICRORNA 24; MICRORNA 378; UNCLASSIFIED DRUG; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; NASOPHARYNX CARCINOMA; PILOT STUDY; SENSITIVITY AND SPECIFICITY; YOUNG ADULT; BLOOD; GENETICS; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PROGNOSIS;

ADOLESCENT; ADULT; AGED; BIOMARKERS, TUMOR; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; YOUNG ADULT;

EID: 84891816523     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.26170     Document Type: Article

References (38)

1. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell 2004; 5:423-8; PMID:15144950; http://dx.doi.org/10.1016/S1535-6108(04)00119-9 (Pubitemid 38612865)
2. Busson P, Keryer C, Ooka T, Corbex M. EBVassociated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. Trends Microbiol 2004; 12:356-60; PMID:15276610; http://dx.doi.org/10.1016/j.tim.2004.06.005 (Pubitemid 38987821)
3. Abdulamir AS, Hafidh RR, Abdulmuhaimen N, Abubakar F, Abbas KA. The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types. BMC Public Health 2008; 8:400; PMID:19055849; http://dx.doi.org/10.1186/1471-2458-8-400
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97; PMID:14744438; http://dx.doi.org/10.1016/S0092-8674(04)00045- 5
5. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-5; PMID:15372042; http://dx.doi.org/10.1038/nature02871 (Pubitemid 39265675)
6. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB, Bartel DP. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 2005; 310:1817-21; PMID:16308420; http://dx.doi.org/10.1126/ science.1121158 (Pubitemid 41814382)
7. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39(Database issue):D152-7; PMID:21037258; http://dx.doi.org/10.1093/nar/gkq1027
8. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, Feig C, Lengyel E, Peter ME. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A 2007; 104:11400-5; PMID:17600087; http://dx.doi.org/10.1073/pnas.0704372104 (Pubitemid 47175152)
9. Sarkar FH, Li Y, Wang Z, Kong D, Ali S. Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Updat 2010; 13:57-66; PMID:20236855; http://dx.doi.org/10.1016/j.drup.2010.02.001
10. Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11:849-64; PMID:22113163; http://dx.doi.org/10.1038/nrc3166
11. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology 2007; 39:197-207; PMID:17454749; http://dx.doi.org/10.1080/00313020701230831 (Pubitemid 46439650)
12. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008; 3:e3694; PMID:19002258; http://dx.doi.org/10.1371/journal.pone.0003694
13. Schöler N, Langer C, Döhner H, Buske C, Kuchenbauer F. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Exp Hematol 2010; 38:1126-30; PMID:20977925; http://dx.doi.org/10. 1016/j.exphem.2010.10.004
14. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141:672-5; PMID:18318758; http://dx.doi.org/10. 1111/j.1365-2141.2008.07077.x (Pubitemid 351667616)
15. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-9; PMID:17486113; http://dx.doi.org/10.1038/ncb1596 (Pubitemid 47214727)
16. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18:997-1006; PMID:18766170; http://dx.doi.org/10.1038/cr.2008.282
17. Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010; 101:2087-92; PMID:20624164; http://dx.doi.org/10.1111/j.1349-7006.2010.01650.x
18. Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, Stanietsky N, Mandelboim M, Mandelboim O. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol 2008; 9:1065-73; PMID:18677316; http://dx.doi.org/10.1038/ni.1642
19. Iguchi H, Kosaka N, Ochiya T. Secretory microRNAs as a versatile communication tool. Commun Integr Biol 2010; 3:478-81; PMID:21057646; http://dx.doi.org/10.4161/cib.3.5.12693
20. Navarro A, Monzo M. MicroRNAs in human embryonic and cancer stem cells. Yonsei Med J 2010; 51:622-32; PMID:20635434; http://dx.doi.org/10.3349/ymj.2010. 51.5.622
21. Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 2010; 77:502-14; PMID:20235276; http://dx.doi.org/10.1002/cyto.a.20886
22. Weiland M, Gao XH, Zhou L, Mi QS. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol 2012; 9:850-9; PMID:22699556; http://dx.doi.org/10.4161/rna.20378
23. Ma R, Jiang T, Kang X. Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res 2012; 31:38; PMID:22546315; http://dx.doi.org/10.1186/1756-9966-31-38
24. Cosmopoulos K, Pegtel M, Hawkins J, Moffett H, Novina C, Middeldorp J, Thorley-Lawson DA. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 2009; 83:2357-67; PMID:19091858; http://dx.doi.org/10.1128/JVI.02104-08
25. Chen HC, Chen GH, Chen YH, Liao WL, Liu CY, Chang KP, Chang YS, Chen SJ. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer 2009; 100:1002-11; PMID:19293812; http://dx.doi.org/10.1038/sj.bjc. 6604948
26. Li T, Chen JX, Fu XP, Yang S, Zhang Z, Chen KhH, Li Y. microRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep 2011; 25:1353-63; PMID:21373758
27. Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 2012; 118:698-710; PMID:21720996; http://dx.doi.org/10. 1002/cncr.26309
28. He ML, Luo MX, Lin MC, Kung HF. MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma. Biochim Biophys Acta 2012; 1825:1-10; PMID:21958739
29. Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei RR, Zhang MY, Sun Y, Huang BJ, Chen M, et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol 2012; 13:633-41; PMID:22560814; http://dx.doi.org/10.1016/S1470-2045(12)70102-X
30. Mao YP, Li WF, Chen L, Sun Y, Liu LZ, Tang LL, Cao SM, Lin AH, Hong MH, Lu TX, et al. [A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma]. Ai Zheng 2009; 28:1022-8; PMID:19799808; http://dx.doi.org/10.5732/cjc.009.10425
31. Lin ZX, Yang ZN, Zhan YZ, Xie WJ, Li GW, Feng HT. [Application study of the 2008 staging system of nasopharyngeal carcinoma]. Ai Zheng 2009; 28:1029-32; PMID:19799809; http://dx.doi.org/10.5732/cjc.009.10431
32. Scott PW. Making a spectacle. Vet Rec 1992; 130:232; PMID:1566538; http://dx.doi.org/10.1136/vr.130.11.232
33. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009; 13:39-53; PMID:19175699; http://dx.doi.org/10.1111/j.1582-4934.2008. 00556.x
34. Jazbutyte V, Thum T. MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 2010; 11:926-35; PMID:20415649; http://dx.doi.org/10.2174/ 138945010791591403
35. Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS, Chang KW. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol 2010; 46:204-8; PMID:20138800; http://dx.doi.org/10.1016/ j.oraloncology.2009.12.005
36. Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, Wang JF, Zhang Z, Lu S, Huang X, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011; 29:4781-8; PMID:22105822; http://dx.doi.org/10.1200/JCO.2011.38.2697
37. Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu Z, Fang H, Zhang J, Katz RL, Jiang F. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer 2010; 127:2870-8; PMID:21351266; http://dx.doi.org/10. 1002/ijc.25289
38. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262 (Pubitemid 34164012)